QCI Interpret One: Oncology variant interpretation just got more precise
Description
Competing to offer a comprehensive genomic profiling service for solid or hematology oncology tumor samples is challenging, especially as panels increase in complexity and size. QIAGEN created QCI Interpret One by combining the flexible and automatable QCI software, powered by superior structured content in the QIAGEN Clinical Knowledge Base, with the trusted services of N-of-One, a world-leading provider of somatic variant interpretation.
Lab Directors can now confidently interpret variants with variant- and disease-specific, oncologist-reviewed content. They can accelerate turnaround time by generating reports in minutes with automated classification of variant actionability and on-demand access to comprehensive expert variant interpretation without the time consuming step of researching and writing evidence-based summaries. They get access to an “expert second opinion” for variant classification, and they can deliver professional reports directly to physicians to help inform clinical decision making.
Interested in learning more?
Click here
Speakers:
Beate Litzenburger, PhD, Global Product Director of Oncology for Clinical Decision Support Software and Interpretation Services at QIAGEN
Sheryl Krevsky Elkin, PhD, Chief Scientific Officer at N-of-One, a QIAGEN company
United States
